Shares of BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) were down 0.9% during mid-day trading on Tuesday . The company traded as low as $10.20 and last traded at $10.2160. Approximately 1,302 shares changed hands during trading, a decline of 55% from the average daily volume of 2,874 shares. The stock had previously closed at $10.31.
BioSyent Stock Down 0.9%
The firm has a 50 day moving average price of $10.21 and a 200-day moving average price of $10.27.
About BioSyent
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
Read More
- Five stocks we like better than BioSyent
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
